Health Care Utilization
Faculty Discussant: A. Simon Pickard, PhD Article 1: Real-World Cost-Effectiveness Analysis of Allogeneic Hematopoietic Stem Cells Transplantation vs. Hydroxyurea Therapy in Children with Sickle Cell Disease Jifang Zhou, MD, MPH; Gregory S. Calip, PharmD, MPH, PhD Article 2: Fondaparinux Sodium Comp...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_f193bf9e7f8e4c70a80d1a846b224ed9 | ||
042 | |a dc | ||
100 | 1 | 0 | |a MIDWEST SAPH 2018 |e author |
245 | 0 | 0 | |a Health Care Utilization |
260 | |b University of Minnesota Libraries Publishing, |c 2018-10-01T00:00:00Z. | ||
500 | |a 10.24926/iip.v0i0.1489 | ||
500 | |a 2155-0417 | ||
520 | |a Faculty Discussant: A. Simon Pickard, PhD Article 1: Real-World Cost-Effectiveness Analysis of Allogeneic Hematopoietic Stem Cells Transplantation vs. Hydroxyurea Therapy in Children with Sickle Cell Disease Jifang Zhou, MD, MPH; Gregory S. Calip, PharmD, MPH, PhD Article 2: Fondaparinux Sodium Compared with Low Molecular Weight Heparins for Thromboprophylaxis among the Patients with Orthopedic Immobility: A Systematic Review and Meta-Analysis Arun Kumar PharmD, MS; Ashna Talwar, BPharm; Wenchen Wu, PhD; Joel F Farley, PhD Article 3: Differences by Primary Insurance in 30-day All-cause Readmission for Patients Undergoing Breast Cancer Surgeries Ming Chen, MS, MSPharm; Shelley Irene White-Means, PhD, MA; Sam Li, PhD, MS Article 4: Seasonal Variation in Heart Failure Hospitalizations in the United States Kendra Y. Foster, MS; Linnea A. Polgreen, PhD Article 5: Antidiabetic Medications among People 20 years and Older and with Diabetes in the United States Julie Zhiying Zhao, MPH; Angeline Carlson, PhD Article 6: Healthcare Utilization in Type 2 Diabetes Patients Using DPP-4 inhibitors and GLP-1 Agonists Sajan Pandya BPharm; Monica Hwang, PhD Article 7: Estimating the Impact of the Food and Drug Administration's (FDA) Unapproved Drug Initiative (UDI) on Drug Prices and Expenditures Sharma D; Schumock GT; Saffore C; Edwards SA; Walton SM | ||
546 | |a EN | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n INNOVATIONS in Pharmacy (2018) | |
787 | 0 | |n https://pubs.lib.umn.edu/index.php/innovations/article/view/1489 | |
787 | 0 | |n https://doaj.org/toc/2155-0417 | |
856 | 4 | 1 | |u https://doaj.org/article/f193bf9e7f8e4c70a80d1a846b224ed9 |z Connect to this object online. |